Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update

American Heart Journal(2020)10.1016/j.ahj.2020.12.007Source: DataRank Database

Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update is a research paper published in American Heart Journal (2020). On theSindex it has a DataRank of 0. It has been cited 52 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

52 citations

Free full text

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)OA: closedTopics (28)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (0/2)

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Subhi J. Al’Aref ORCID,Muhammad Shahzeb Khan ORCID,Malek Al‐Hawwas,Srikanth Vallurupalli ORCID,Jawahar L. Mehta

Live enrichment

PubMed:33385359

National Institutes of Health

Grant: 2R01 HL127661-05

closedLicense: https://www.elsevier.com/legal/tdmrep-license

publisherhttps://api.elsevier.com/content/article/PII:S0002870320304063?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0002870320304063?httpAccept=text/plain

Fields of Study

Benzhydryl CompoundsCardiovascular SystemCause of DeathDiabetes Mellitus, Type 2Glomerular Filtration RateGlucosidesGlycosidesHospitalizationHumansKidneyKidney DiseasesRandomized Controlled Trials as TopicSodium-Glucose Transporter 1Sodium-Glucose Transporter 2 Inhibitors

MeSH Terms

KidneyCardiovascular SystemHumansKidney DiseasesDiabetes Mellitus, Type 2Benzhydryl CompoundsGlycosidesGlucosidesGlomerular Filtration RateHospitalizationCause of DeathSodium-Glucose Transporter 1Randomized Controlled Trials as TopicSodium-Glucose Transporter 2 Inhibitors

Additional file 1 of Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis

10.6084/m9.figshare.19128968.v1figshare

10.6084/m9.figshare.19128968figshare

Additional file 1 of Association of sodium-glucose cotransporter 2 inhibitors with risk of major adverse cardiovascular events in type 2 diabetes patients with acute coronary syndrome: a propensity score‑matched analysis

10.6084/m9.figshare.25478853.v1figshare

10.6084/m9.figshare.25478853figshare

Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update

FAIR Checklist

Authors (11)

Funding (1 grants)

Open Access

Topics

Linked Datasets (4)